Skip to main content
RT @synovialjoints: The highlight of the last day of #ACR19 is the Rheumatology Roundup Highlights #ACRBest by Drs. John Cush @RheumNow and…

Dr. Antoni Chan synovialjoints

8 months ago
The highlight of the last day of #ACR19 is the Rheumatology Roundup Highlights #ACRBest by Drs. John Cush @RheumNow and Arthur Kavanaugh @ACRheum always worth attending with great take home messages #rheum https://t.co/eMdvc2byKG
RT @cappelliMD: Hope to have many more interdisciplinary discussions re. irAEs #ACR19 @LCalabreseDO @CCalabreseDO @EladSharonMD @DrJNaidoo…

Laura Cappelli cappelliMD

8 months ago
Hope to have many more interdisciplinary discussions re. irAEs #ACR19 @LCalabreseDO @CCalabreseDO @EladSharonMD @DrJNaidoo @UmaThanaMD @lexmeara @drdavidliew https://t.co/8KDorKW2WJ
RT @Janetbirdope: Great ACR 2019. We weathered the weather #ACR @RheumNow https://t.co/lCKxADudRf

Janet Pope Janetbirdope

8 months ago
Great ACR 2019. We weathered the weather #ACR @RheumNow https://t.co/lCKxADudRf
RT @philipcrobinson: Different centres have different yields from temporal artery biopsy independent of biopsy length #ACR19 @RheumNow Abs…

Philip Robinson philipcrobinson

8 months ago
Different centres have different yields from temporal artery biopsy independent of biopsy length #ACR19 @RheumNow Abs 2685 https://t.co/Gqy9sY4OrM
RT @ALGaffoRheumMD: Just took few pictures during social media gathering yesterday at #ACR19. It was so nice to meet everyone. Thanks to @p…

Angelo Gaffo ALGaffoRheumMD

8 months ago
Just took few pictures during social media gathering yesterday at #ACR19. It was so nice to meet everyone. Thanks to @psufka for organizing and it was nice to meet the man behind the legend! @Drbeckyg @maio_danila https://t.co/lSpPz0V4ng
RT @DrJuanOvalles: Therapeutic approach to skin in #Scleroderma
#ACR19 https://t.co/ZV8J5Z0wum

Juan Ovalles, MD, PhD DrJuanOvalles

8 months ago
Therapeutic approach to skin in #Scleroderma #ACR19 https://t.co/ZV8J5Z0wum
RT @DrKanikaMonga: Myositis Treatment Pearls
- Optimize drug dose and allow adequate time to reach effectiveness
- Steroids NOT always nece…

Kanika Monga, MD DrKanikaMonga

8 months ago
Myositis Treatment Pearls - Optimize drug dose and allow adequate time to reach effectiveness - Steroids NOT always necessary - Steroids and IVIG are the fastest acting agents - Reasons for admission: dysphagia and SOB
RT @psufka: Primary care providers - take a look at these new gout guidelines. They're very straightforward, and your patients will do much…

Dr. Paul Sufka psufka

8 months ago
Primary care providers - take a look at these new gout guidelines. They're very straightforward, and your patients will do much better than if you follow the ACP guidelines. #ACR19 https://t.co/BIGLj6GKRe
RT @Lupusreference: Hello #ACR19. Are you still confused 😲 about the #pathways of #JAK-inhibitors and #Interferon-blocking strategies in #L…

Laurent ARNAUD Lupusreference

8 months ago
Hello #ACR19. Are you still confused 😲 about the #pathways of #JAK-inhibitors and #Interferon-blocking strategies in #Lupus? Check up this refresher slide showing what these #SLE #treatments target!! 🎯 https://t.co/ZNnJTkz4nK
RT @CCalabreseDO: That’s a wrap on #ACR2019 ! Check out @RheumNow for meeting coverage, and see you next year in DC! @LCalabreseDO #cleclin…

Cassandra Calabrese CCalabreseDO

8 months ago
That’s a wrap on #ACR2019 ! Check out @RheumNow for meeting coverage, and see you next year in DC! @LCalabreseDO #cleclinicrheum https://t.co/sx2M5sD6pU
RT @Janetbirdope: Never thought I'd say it. ACR in beautiful Atlanta. Kind of grows on you. #ACR #ACR19 @RheumNow https://t.co/YJOi5lEQei

Janet Pope Janetbirdope

8 months ago
Never thought I'd say it. ACR in beautiful Atlanta. Kind of grows on you. #ACR #ACR19 @RheumNow https://t.co/YJOi5lEQei
RT @psufka: My post on @RheumNow: “Muscle loss and frailty in rheumatic disease" https://t.co/lpTBAPkrbV #ACR19

Dr. Paul Sufka psufka

8 months ago
My post on @RheumNow: “Muscle loss and frailty in rheumatic disease" https://t.co/lpTBAPkrbV #ACR19
RT @hausmannMD: The most interesting disease topic of #ACR19? Systemic JIA-associated lung disease. An increasingly recognized complication…

Jonathan Hausmann MD hausmannMD

8 months ago
The most interesting disease topic of #ACR19? Systemic JIA-associated lung disease. An increasingly recognized complication of #SJIA with poor prognosis. https://t.co/ySHLbU5Pjc @RheumNow
RT @uptoTate: Asymptomatic sacroiliitis was observed in about 15% of young IBD pts. Entero MRI may be helpful for early inflammatory change…

Dr. Rachel Tate uptoTate

8 months ago
Asymptomatic sacroiliitis was observed in about 15% of young IBD pts. Entero MRI may be helpful for early inflammatory changes in IBD pts. abst #1174 #ACR19 @RheumNow https://t.co/sQxj8cmuKd
RT @Janetbirdope: Thanks. I forgot about low all phosph as a tip off for hypophosphatemia. Results in CPPD, calcific tendonitis and osteopo…

Janet Pope Janetbirdope

8 months ago
Thanks. I forgot about low all phosph as a tip off for hypophosphatemia. Results in CPPD, calcific tendonitis and osteoporosis #ACR @RheumNow https://t.co/RkoeRAXggt
sunset bench exercise
Muscle Loss and Frailty in Rheumatic Disease
Paul Sufka, MD
“If exercise could be purchased in a pill, it would be the single most widely prescribed and beneficial medicine in the nation.” —Robert H. Butler, MD, first director of the National Institute on Aging.
RT @DrKanikaMonga: 2020 Gout Clinical Practice Guideline‼️ For patients with gout where XOI, uricosurics and other interventions have fail…

Kanika Monga, MD DrKanikaMonga

8 months ago

2020 Gout Clinical Practice Guideline ‼️ For patients with gout where XOI, uricosurics and other interventions have failed to achieve serum urate target/ FREQUENT flares/ NON-RESOLVING tophi, strongly recommend switching to pegloticase over continuing current ULT #ACR19 @RheumNow

RT @DrKanikaMonga: Myositis -
specific organ involvement
joints: MTX, rituximab, abatacept
lung: azathioprine, mycophenolate, rituximab
ski…

Kanika Monga, MD DrKanikaMonga

8 months ago
Myositis - specific organ involvement joints: MTX, rituximab, abatacept lung: azathioprine, mycophenolate, rituximab skin: mycophenolate #ACR19 @RheumNow
Lupus Pearls: Dr. Kathryn Dao

Dr. Dao reviews several lupus pearls delivered by Dr. Michelle Petri at the 2019 ACR/ARP annual meeting in Atlanta. 

lung
Systemic JIA-associated Lung Disease
Jonathan Hausmann, MD
A disease you’ve never heard of is becoming increasingly common and carries a very poor prognosis. 
Tofacitinib as Monotherapy Following MTX Withdrawal in PsA: Dr. Eric Ruderman

Dr. Ruderman describes abstract #L14 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

RT @uptoTate: Behcets - oral ulcers not NECESSARY for dx and 20% may present with uveitis. Revascularization not recommended for Takayasu a…

Dr. Rachel Tate uptoTate

8 months ago
Behcets - oral ulcers not NECESSARY for dx and 20% may present with uveitis. Revascularization not recommended for Takayasu as first line tx- get inflammation under control. Good skin biopsy needs fat to diagnose medium vessel vasculitis so go deep. Dr. West #ACR19 @RheumNow
RT @alibafer: Estos mensajes son los que me gustan indicar y comprometer a nuestros pacientes que la indicación que lo mejora está en su mo…

Miguel Albanese alibafer

8 months ago
Estos mensajes son los que me gustan indicar y comprometer a nuestros pacientes que la indicación que lo mejora está en su modo de vida y no solo en un medicamento Los médicos son grandes educadores primero y luego prescriben https://t.co/BLKJ8Yytex
RT @uptoTate: Dr. West’s pearls continued. GPA arthritis usually affects LE, is migratory + can be the first manifestation of vasculitis. #…

Dr. Rachel Tate uptoTate

8 months ago
Dr. West’s pearls continued. GPA arthritis usually affects LE, is migratory + can be the first manifestation of vasculitis. #ACR19 @RheumNow #ACRbest
RT @uptoTate: Pearls from Dr. West. GCA oral ulcers usually mid portion of lat tongue. If neutrophils or necrosis on TAB then could be ANCA…

Dr. Rachel Tate uptoTate

8 months ago
Pearls from Dr. West. GCA oral ulcers usually mid portion of lat tongue. If neutrophils or necrosis on TAB then could be ANCA vasculitis. For GPA scleritis use rituximab first. GPA can cause 7th nerve palsy + facial droop. #ACR19 @RheumNow #ACRbest
RT @MeralElRamahiMD: The amazing Metabolic Bone Disease expert, @CLDeal, recaps pearls on an important, under-diagnosed disease! #CleClinic…

Meral K. El Ramahi, MD MeralElRamahiMD

8 months ago
The amazing Metabolic Bone Disease expert, @CLDeal, recaps pearls on an important, under-diagnosed disease! #CleClinicRheum #ACR19 @abelsoa @RulaHajjAliMD @CCalabreseDO @LCalabreseDO https://t.co/dsMRpfzJFY
RT @HopkinsMedNews: Laura Cappelli organized an open discussion at #ACR19 between oncologists and rheumatologists addressing the rheumatic…

Hopkins Med News HopkinsMedNews

8 months ago
Laura Cappelli organized an open discussion at #ACR19 between oncologists and rheumatologists addressing the rheumatic problems seen in some patients on cancer-fighting check point inhibitors. https://t.co/iOtJq6gwh9
RT @uptoTate: Dr. West’s #ACR19 pearls. Idiopathic orbital inflammation- think sarcoid, vasculitis, igG4-get biopsy. In IgG4 hypocomplement…

Dr. Rachel Tate uptoTate

8 months ago
Dr. West’s #ACR19 pearls. Idiopathic orbital inflammation- think sarcoid, vasculitis, igG4-get biopsy. In IgG4 hypocomplementemia implies renal involvement, LN bx not useful but may also help rule out lymphoma or infection. @RheumNow
Use of MRI in GCA: Drs. Arthur Lau and Mats Junek

Dr. Lau interviews Dr. Janek on abstract #2660 at the 2019 ACR/ARP annual meeting in Atlanta. 

SJIA-associated ILD: Dr. Jonathan Hausmann

Dr. Hausmann describes a new inflammatory lung disease at the 2019 ACR/ARP annual meeting in Atlanta. 

Pearls of IgG4 Related Disease: Dr. Paul Sufka

Dr. Sufka reviews Dr. Stone's review session on IGg4-related disease from the 2019 ACR/ARP annual meeting in Atlanta. 

Rheumatology Pearls from Dr. Sterling West: Dr. Kathryn Dao

Dr. Dao shares pearls presented by Dr. West at the 2019 ACR/ARP annual meeting in Atlanta. 

RT @synovialjoints: Results from2 anti-IL-17 agents Secukinumab and Ixekizumab in non-radiographic axial Spondyloarthritis poster #L2 and a…

Dr. Antoni Chan synovialjoints

8 months ago

Results from2 anti-IL-17 agents Secukinumab and Ixekizumab in non-radiographic axial Spondyloarthritis poster #L2 and abstract #2729 is promising as treatment options for patients #ACR19 @RheumNow

RT @synovialjoints: The ASAS40 and all major secondary endpoints for Ixekizumab Q4W and Q2W were met at Wk 16 and Wk 52 with no unexpected…

Dr. Antoni Chan synovialjoints

8 months ago

The ASAS40 and all major secondary endpoints for Ixekizumab Q4W and Q2W were met at Wk 16 and Wk 52 with no unexpected safety findings. IXE superior to PBO for improving signs, symptoms, and inflammation on MRI in pts with nr-axSpA abstract #2729 #ACR19 @RheumNow

×